Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort study.
Maelle Le BrasHélène LeclercOlivia RousseauPierre GoudetThomas CunyCastinetti FredericCatherine BautersPhilippe ChansonAntoine TabarinSebastien GaujouxSophie Christin-MaitrePhilippe RuszniewskiFrancoise Borson-ChazotIsabelle GuilhemPhilippe CaronBernard GoichotAlbert BeckersBrigitte DelemerIsabelle RaingeardBruno VergèsSarra SmatiMatthieu WargnyBertrand CariouSamy HadjadjPublished in: European journal of endocrinology (2021)
PAs in patients with MEN1 are less aggressive than previously thought. Tumour progression is rare with a standard of care monitoring and treatment, especially in related patients who mostly present non-secreting microadenoma. MRI monitoring for asymptomatic MEN1 patients should be reduced accordingly.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- healthcare
- chronic kidney disease
- magnetic resonance imaging
- prognostic factors
- peritoneal dialysis
- middle aged
- contrast enhanced
- quality improvement
- patient reported outcomes
- computed tomography
- magnetic resonance
- chronic pain
- smoking cessation
- replacement therapy
- growth hormone